Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin Disorders.
Cell Differentiation
Chromatin
Chromatin Immunoprecipitation
Connectome
Enhancer Elements, Genetic
/ genetics
Genetic Predisposition to Disease
Genome-Wide Association Study
Histones
/ genetics
Humans
Ikaros Transcription Factor
/ genetics
Inflammation
/ genetics
Interferon Regulatory Factors
/ genetics
Janus Kinases
/ metabolism
Lupus Erythematosus, Systemic
/ genetics
Polymorphism, Single Nucleotide
STAT Transcription Factors
Signal Transduction
Skin Diseases
/ genetics
T-Lymphocytes, Regulatory
/ physiology
Th17 Cells
/ physiology
Journal
The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
29
03
2018
revised:
24
08
2018
accepted:
18
09
2018
pubmed:
14
10
2018
medline:
25
2
2020
entrez:
14
10
2018
Statut:
ppublish
Résumé
The vast majority of polymorphisms for human dermatologic diseases fall in noncoding DNA regions, leading to difficulty interpreting their functional significance. Recent work using chromosome conformation capture technology in combination with chromatin immunoprecipitation (ChIP) has provided a systematic means of linking noncoding variants in active enhancer loci to putative gene targets. Here, we apply H3K27ac HiChIP high-resolution contact maps, generated from primary human T-cell subsets (CD4
Identifiants
pubmed: 30315781
pii: S0022-202X(18)32657-5
doi: 10.1016/j.jid.2018.09.011
pii:
doi:
Substances chimiques
Chromatin
0
Histones
0
Interferon Regulatory Factors
0
STAT Transcription Factors
0
interferon regulatory factor-8
0
Ikaros Transcription Factor
148971-36-2
Janus Kinases
EC 2.7.10.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
605-614Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.